HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.

AuthorsAntonio Salar, Eva Domingo-Domenech, Carlos Panizo, Concepción Nicolás, Joan Bargay, Ana Muntañola, Miguel Canales, José Luis Bello, Juan Manuel Sancho, José Francisco Tomás, María José Rodríguez, Javier Peñalver, Carlos Grande, José Javier Sánchez-Blanco, Luis Palomera, Reyes Arranz, Eulogio Conde, Mar García, Juan Fernando García, Dolores Caballero, Carlos Montalbán
JournalBlood (Blood) Vol. 130 Issue 15 Pg. 1772-1774 (10 12 2017) ISSN: 1528-0020 [Electronic] United States
PMID28801448 (Publication Type: Clinical Trial, Phase II, Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Rituximab
  • Bendamustine Hydrochloride
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bendamustine Hydrochloride (therapeutic use)
  • Female
  • Humans
  • Longitudinal Studies
  • Lymphoma, B-Cell, Marginal Zone (drug therapy, mortality)
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Remission Induction
  • Rituximab (therapeutic use)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: